Silvia Carolina Villacres Gavilanes

Silvia Carolina Villacres Gavilanes

Auto-generated profile, based on publicly available information

Silvia Carolina Villacres Gavilanes

Universidad Técnica de Ambato

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2023 in Revista Medica Sinergia
Verified
Journal Article
Open access
PDF file
EBEdisson Javier Fiallos Brito
Edisson Javier Fiallos Brito
IYIván Guillermo Toapanta Yugcha
Iván Guillermo Toapanta Yugcha
SGSilvia Carolina Villacrés Gavilanes
Silvia Carolina Villacrés Gavilanes
Revista Médica Sinergia es una revista de acceso abierto con sede en Costa Rica. Su objetivo es difundir la produccion científica de todos los campos de la ciencia médica y afines, tenemos como mision llegar a ser una herramienta valiosa para la difusión de investigaciones en el área de salud a nivel internacional. Su área de cobertura temática, son los temas relacionados con la ciencia de la salud (medicina interna, ginecologia y obstetricia, cirugia, pediatria, etc.). Esto se lleva a cabo mediante publicaciones mensuales de artículos de revisiones bibliográficas, investigación, comunicación científica y reporte de casos. La revista va dirigida primordialmente al personal medico y ciencias relacionadas al área de la salud. Todos los artículos son originales, con temas de alto interés para la comunidad médica y para el área de la salud en general. We present the case of a 9-year-old female patient, with a history of prematurity, and growth stubbornness, presenting with clinical picture of early-onset poikiloderma with different clinical features including short stature, sparse eyelashes or eyebrows, with suspected Bloom syndrome vs Rothmund-Thomson syndrome, which was addressed by studying the BLM and RECQL4 genes. Se presenta el caso de una paciente femenina de 9 años de edad, con antecedentes de prematuridad, y retazo del crecimiento, que cursa con cuadro clínico de poiquilodermia de inicio temprano con diferentes características clínicas que incluyen talla baja, pestañas o cejas escasas, con sospecha de síndrome de Bloom vs síndrome de Rothmund-Thomson, el cual se abordó mediante el estudio de los genes BLM y RECQL4.

1 July 2026 in Salud Medicina e Innovación Journal
Verified
Journal Article
Open access
PDF file
SGSilvia Carolina Villacres Gavilanes
Silvia Carolina Villacres Gavilanes
JHJacqueline Estefanía Alarcón Herrera
Jacqueline Estefanía Alarcón Herrera
LLLissette Alejandra Tisalema Laura
Lissette Alejandra Tisalema Laura
GVGabriela Abigail Ortega Villacreses
Gabriela Abigail Ortega Villacreses
MMMaría Paula Villagomez Mayorga
María Paula Villagomez Mayorga
Introduction: Seizures are among the most common neurological emergencies in childhood. Accurately determining which patients require long-term antiseizure medication (ASM) therapy and which may be managed exclusively through clinical observation remains a significant clinical challenge. Objective: To analyze and standardize the clinical, electroencephalographic, and neuroimaging criteria used to distinguish pediatric patients with seizures who require pharmacological treatment from those who may be managed through observation. Methods: A systematic exploratory search was conducted in indexed databases, including PubMed, ScienceDirect, SciELO, and the Cochrane Library, using DeCS/MeSH terms. Clinical practice guidelines, meta-analyses, and clinical trials published between 2021 and 2026 were selected. Results: The available evidence indicates that a first unprovoked seizure is associated with a recurrence risk of approximately 40–50%; therefore, close clinical observation is generally the preferred management strategy. Long-term pharmacological treatment is indicated when the estimated risk of recurrence exceeds 60%, particularly in the presence of clear epileptiform discharges on electroencephalography, an abnormal baseline neurological examination, structural abnormalities on neuroimaging, or status epilepticus at presentation. Conclusion: In pediatric patients, the decision to initiate antiseizure therapy should not be determined by the dramatic clinical appearance of the first seizure. Instead, it should be based on an objective assessment of recurrence risk and a careful evaluation of the benefit–risk profile of antiseizure medications (American Academy of Pediatrics, 2022; Berg et al., 2022; National Institute for Health and Care Excellence, 2022).

1 July 2026 in Salud Medicina e Innovación Journal
Verified
Journal Article
Open access
PDF file
SGSilvia Carolina Villacres Gavilanes
Silvia Carolina Villacres Gavilanes
MMMaría Paula Villagomez Mayorga
María Paula Villagomez Mayorga
LFLenin Carlos Gabriel Flores
Lenin Carlos Gabriel Flores
CGChristian Fernando Ocaña Guzmán
Christian Fernando Ocaña Guzmán
JQJohana Estefania Orna Quintanilla
Johana Estefania Orna Quintanilla
Pediatric nemaline myopathy is the most common non-dystrophic congenital myopathy, yet its clinical and genetic expression varies widely across patients. This study synthesizes the published evidence on clinical manifestations, genetic alterations, and mortality in pediatric patients with this diagnosis, through a systematic review of case reports and case series conducted according to the PRISMA 2020 guidelines, searching PubMed, Scopus, Web of Science, Cochrane Library, and Dialnet between 2010 and 2022. Ten studies met the inclusion criteria, contributing a total of 63 patients. ACTA1 (45.7%) and NEB (40.0%) accounted for most of the mutations identified. Clinically, axial and proximal muscle weakness (24.75%) and neonatal hypotonia (23.76%) predominated. Five patients died (7.9%), mainly from respiratory failure. These findings confirm a markedly heterogeneous disease, with persistent gaps in genetic characterization that support the need for multicenter studies with standardized methodology.

21 October 2025 in Andes Pediatrica
Verified
Journal Article
Open access
PDF file
EAEddy Efren Balseca Artos
Eddy Efren Balseca Artos
Carolina CampoverdeCarolina Campoverde
Carolina Campoverde
EBEdisson Javier Fiallos Brito
Edisson Javier Fiallos Brito
SGSilvia Carolina Villacrés Gavilanes
Silvia Carolina Villacrés Gavilanes
El estreñimiento funcional en niños es un trastorno común que afecta a una gran proporción de la población a nivel mundial, con un impacto significativo en la calidad de vida de los pacientes y sus familias. A pesar de las estrategias convencionales, como el uso de laxantes y los cambios en la dieta, muchos niños continúan experimentando síntomas persistentes. Objetivo: Realizar una revisión narrativa sobre las estrategias terapéuticas en el manejo del estreñimiento funcional en niños, evaluando su eficacia y seguridad. Material y Método: Revisión de la literatura cient.íica publicada entre 2020 y 2025 en bases de datos como PubMed, Scopus y Web of Science según criterios SANRA. Se seleccionaron estudios de alta calidad metodológica, incluidos ensayos clínicos, revisiones sistemáticas y guías clínicas. Resultados: Se identificaron diversas estrategias terapéuticas, como el uso de prebióticos, probióticos, nuevas formulaciones farmacológicas y terapias combinadas, que han demostrado eficacia en el tratamiento del estreñimiento funcional. Conclusiones: El estreñimiento funcional pediátrico afecta significativamente la calidad de vida. Su manejo debe ser individualizado, centrado en los cambios de estilo de vida, educación familiar, dieta y tratamiento farmacológico.

1 July 2026 in Salud Medicina e Innovación Journal
Verified
Journal Article
Open access
PDF file
SGSilvia Carolina Villacres Gavilanes
Silvia Carolina Villacres Gavilanes
JHJacqueline Estefanía Alarcón Herrera
Jacqueline Estefanía Alarcón Herrera
LLLissette Alejandra Tisalema Laura
Lissette Alejandra Tisalema Laura
JRJohn Alexander Rueda Ruiz
John Alexander Rueda Ruiz
Developmental hip dysplasia (DHD) is the most significant orthopedic condition in childhood and is one of the causes of musculoskeletal disability when diagnosis is delayed. The objective of this review was to analyze recent scientific evidence on neonatal screening strategies and the main diagnostic errors associated with DHD. A systematic review of the scientific evidence was conducted following the recommendations established by the PRISMA flowchart; the main objective was to identify, analyze, and establish the best available recommendations regarding DDH. To this end, a search was conducted for the best scientific literature published between 2020 and 2025 in specialized databases and clinical guidelines. After applying the previously defined selection criteria, 15 studies that met the established methodological requirements were included. The analyzed findings suggest that universal ultrasound screening programs may promote the early identification of cases of developmental dysplasia of the hip (DDH) and reduce the frequency of late diagnoses, as well as the need for surgical interventions, compared with strategies based solely on the selection of patients with risk factors. Furthermore, the most common diagnostic errors were related to an inadequate neonatal physical examination, incorrect interpretation of hip ultrasound, and deficiencies in the clinical and ultrasound follow-up of infants with risk factors—factors that increase the likelihood of late diagnosis and functional complications. However, controversies persist regarding the implementation of universal screening, primarily due to inequalities in the availability of resources and in the cost-effectiveness of different health care systems. It is concluded that early detection through standardized screening protocols, along with adequate training of healthcare personnel and timely follow-up of at-risk patients, constitutes the most effective strategy for reducing complications and improving the functional prognosis of children with DDC.

5 October 2026 in Salud Medicina e Innovación Journal
Verified
Journal Article
Open access
PDF file
SGSilvia Carolina Villacres Gavilanes
Silvia Carolina Villacres Gavilanes
LMLissette Cristina Castillo Merino
Lissette Cristina Castillo Merino
LÁLisette Estefanía Reinoso Álvarez
Lisette Estefanía Reinoso Álvarez
BSBrigitte Alexandra Moreno Sánchez
Brigitte Alexandra Moreno Sánchez
Introduction: Fever without a source represents a frequent diagnostic challenge in pediatric emergency care, particularly in children under 5 years of age, due to the difficulty of distinguishing self-limited viral illnesses from serious bacterial infections. Clinical assessment remains fundamental; however, the incorporation of biomarkers, rapid diagnostic tests, and risk-stratification algorithms has modified the diagnostic approach to these patients. Objective: To analyze recent scientific evidence on the diagnostic criteria used in children under 5 years of age presenting with fever without a source, with emphasis on the clinical performance of biomarkers, ancillary diagnostic tests, and risk-stratification algorithms for the early identification of serious bacterial infections. Methods: A systematic literature review was conducted in accordance with PRISMA guidelines. PubMed, Scopus, SciELO, ScienceDirect, and Dialnet were searched. Studies published between 2024 and 2026, in English or Spanish, were included if they addressed fever without a source in pediatric patients under 5 years of age and evaluated diagnostic strategies, biomarkers, clinical algorithms, or ancillary diagnostic tests. Following the identification, screening, and eligibility assessment processes, 25 articles were included in the final synthesis. Results: The reviewed evidence indicates that risk-stratification algorithms, particularly PECARN and Step-by-Step, contribute to identifying patients with different probabilities of serious bacterial infection and may guide decisions regarding additional diagnostic testing and hospital management. Procalcitonin demonstrated favorable diagnostic performance compared with traditional biomarkers in the assessment of febrile infants. Likewise, rapid molecular tests may provide etiological information within a shorter timeframe, although their clinical utility should be interpreted alongside clinical assessment and the epidemiological context. Urinary tract infection was identified as one of the main bacterial infections associated with fever without a source. Conclusions: Current evidence supports an integrated approach combining clinical assessment, biomarkers, and risk-stratification algorithms to guide the diagnosis of serious bacterial infections in children with fever without a source. In Ecuador, limitations related to access to advanced biomarkers, molecular testing, and standardized clinical protocols may hinder the implementation of these strategies. Context-specific protocols and ongoing healthcare professional training are needed to promote evidence-based care and more rational antimicrobial use.